
All transactions are processed in USD.
We Accept VISA/ Master/ E-Check/ Wire Transfers.
| How effective is palbociclib? | Date : Thursday 16 Feb, 2023 |
|---|---|
| FAQ Summary | |
| The median progression-free survival for the 23 patients who got palbociclib as... | |
| FAQ Content: | |
| The median progression-free survival for the 23 patients who got palbociclib as second-line therapy for metastatic breast cancer was 13.3 months (95% CI 4.1-22.4 months). The median progression-free survival among the 7 women who received palbociclib as third-line treatment was 6.0 months (95% CI 0.9-11.1 months). | |
| FAQ Statistics: | |
|
Viewed : 42 Current Reviews : 0 |
|

All transactions are processed in USD.
We Accept VISA/ Master/ E-Check/ Wire Transfers.
Loading

